The Food and Drug Administration has granted EYD-001 orphan drug designation for the treatment of systemic sclerosis.

The rates of sudden unexpected infant death (SUID) and sudden infant death syndrome (SIDS) increased during the intrapandemic period.

The prevalence of osteoporosis and osteoporotic fractures decreased over a 24-year period among patients with rheumatoid arthritis.

Positive topline results were announced from a phase 3 study of obinutuzumab in patients with lupus nephritis.

For plaque or guttate psoriasis, home-based narrowband ultraviolet B phototherapy is as effective as office-based phototherapy.

The AAP has published its first clinical practice guideline on the use of pediatric opioid prescribing to manage acute pain in children.

Lupus nephritis progression may be faster in patients with interstitial fibrosis/tubular atrophy (IFTA). Now a nomogram may predict it.

Targeted therapies for PsA are effective for reducing the use of symptomatic treatments, sick leave, and rates of hospitalization.

Zasocitinib at doses of 5 mg or greater vs placebo resulted in greater skin clearance among patients with moderate to severe plaque psoriasis.

Children born in 2020 to 2021 had lower coverage with nearly all childhood vaccines recommended by age 24 months than those born in 2018 and 2019.

SGLT-2 inhibitor use vs DPP-4 inhibitor use was associated with a lower risk for incidental Parkinson disease among older adults with type 2 diabetes.

Outdoor nighttime light pollution exposure is associated with a higher risk of developing Alzheimer disease, especially among younger adults.